Atea Pharmaceuticals, Inc.
AVIRDrugs in Pipeline
5
Phase 3 Programs
3
Upcoming Catalysts
3
Next Catalyst
Aug 6, 2026
9dMarket Overview
Stock performance and key metrics
4 upcoming, 0 past
AVIR Earnings Report
EPS Est: $-0.56 | FQ end 2026-06
3 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How AVIR's past catalysts played out
Bemnifosbuvir (BEM)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
Bemnifosbuvir-Ruzasvir
HEPATITIS C VIRUS CHRONIC INFECTION
Bemnifosbuvir-Ruzasvir (BEM/RZR)
HEPATITIS C VIRUS CHRONIC INFECTION
Bemnifosbuvir
Chronic Hepatitis C Virus
AT-527
Hepatitis C
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Bemnifosbuvir (BEM) | Phase 3 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection) | - | - |
Bemnifosbuvir-Ruzasvir | Phase 3 | HEPATITIS C VIRUS CHRONIC INFECTION | - | - |
Bemnifosbuvir-Ruzasvir (BEM/RZR) | Phase 3 | HEPATITIS C VIRUS CHRONIC INFECTION | - | - |
Bemnifosbuvir | Phase 2 | Chronic Hepatitis C Virus | - | - |
AT-527 | Phase 2 | Hepatitis C | - | - |
HEPATITIS C VIRUS CHRONIC INFECTION
2 drugs in this indication
Chronic Hepatitis C Virus
1 drug in this indication
Hepatitis C
1 drug in this indication
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Atea Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in Atea Pharmaceuticals, Inc.'s (AVIR) pipeline across Phase 3, Phase 2. Its lead program is Bemnifosbuvir (BEM) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Atea Pharmaceuticals, Inc.'s next FDA catalyst?→
Atea Pharmaceuticals, Inc.'s (AVIR) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track AVIR biotech catalysts?→
Add AVIR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Atea Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.